SCHEMBL12050631

SCHEMBL12050631

CN1C(=O)NC(=O)C12Cc1cc3nc(-c4ccc(N5CCCCC5)cc4)[nH]c3cc1C2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPBWR1 P48145 2/20 0.51
▸ SIRT2 Q8IXJ6 1/20 0.48
▸ SIRT1 Q96EB6 1/20 0.48
▸ DGAT1 O75907 1/20 0.45
▸ SOAT1 P35610 1/20 0.45
▸ KCNH2 Q12809 1/20 0.45
▸ TOP1 P11387 2/20 0.44
▸ TOP2A P11388 2/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ HPGD P15428 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ CALCRL Q16602 1/20 0.43
▸ TNKS O95271 1/20 0.42
▸ PARP1 P09874 1/20 0.42
▸ TNKS2 Q9H2K2 1/20 0.42
▸ AURKA O14965 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ SLCO2B1 O94956 1/20 0.41
▸ GLA P06280 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3391601 0.93 DGAT1 (0.53) NPBWR1DGAT1SOAT1KCNH2TOP1
SCHEMBL12050633 0.84 CALCRL (0.50) NPBWR1DGAT1KCNH2ALDH1A1SMN1; SMN2
SCHEMBL12050634 0.80 CALCRL (0.48) TOP1TOP2AALDH1A1SMN1; SMN2HPGD
SCHEMBL12990912 0.76 AURKA (0.48) NPBWR1SIRT2SIRT1CALCRLAURKA
SCHEMBL14535761 0.76 NPBWR1 (0.42) NPBWR1DGAT1KCNH2ALDH1A1SMN1; SMN2
SCHEMBL12050348 0.74 CALCRL (0.49) CALCRL
SCHEMBL19198151 0.74 SIRT2 (0.59) NPBWR1SIRT2SIRT1DGAT1SOAT1
SCHEMBL12050621 0.74 CALCRL (0.45) CALCRL
SCHEMBL9383621 0.72 NPBWR1 (0.53) NPBWR1SIRT2SIRT1DGAT1SOAT1
SCHEMBL24075401 0.72 NPBWR1 (0.58) NPBWR1SIRT2SIRT1DGAT1SOAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8071770-B2 Spirohydantoin aryl CGRP receptor antagonists MERCK SHARP & DOHME CORP. (US) 2011-12-06 — — US disclosed
US-8071770-B2 Spirohydantoin aryl CGRP receptor antagonists MERCK SHARP & DOHME CORP. (US) 2011-12-06 — — US disclosed
US-20090239870-A1 Spirohydantoin Aryl Cgrp Receptor Antagonists MERCK SHARP & DOHME LLC 2009-09-24 — — US disclosed
US-20090239870-A1 Spirohydantoin Aryl Cgrp Receptor Antagonists MERCK SHARP & DOHME LLC 2009-09-24 — — US disclosed
WO-2007061676-A2 SPIROHYDANTOIN ARYL CGRP RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2007-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239870-A1 Spirohydantoin Aryl Cgrp Receptor Antagonists BDKRB1, BDKRB2, CALCRL NPBWR1 128/4885SIRT2 1750/4885SIRT1 1488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback